Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors. The investigators found that the protein encoded by this gene, called EPHA3, normally inhibits tumor formation, and that loss or mutation of the gene — as often happens in lung cancer — diminishes this [...]

From left, Kelly Boyd, DVM, Ph.D., James Crowe Jr., M.D., William Pao, M.D., Ph.D., Mary Zutter, M.D., and Yu Shyr, Ph.D., share a laugh at last week’s grand opening of the Translational Pathology Shared Resource (TPSR) laboratory in Medical Center North. The TPSR is Vanderbilt’s “pathology powerhouse” and is designed to translate basic science discoveries [...]

Jacek Hawiger Award for Teaching Graduate Students and Postdoctoral Fellows in the Classroom, Lecture or Small Group Setting — Yu Shyr, Ph.D., Ingram Professor of Cancer Research, professor of Biostatistics, Biomedical Informatics, Cancer Biology and Preventive Medicine. Shyr earned his bachelor’s degree in statistics from Tamkang University, Taiwan, in 1985, and his doctorate in biostatistics [...]